Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study

Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand

(2018) Pich Seekaew et al.   PLoS One

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya

(2015) Catherine S. Todd et al.   CONTRACEPTION

Pregnancy and Contraceptive Use Among Women Participating in the FEM-PrEP Trial

(2015) Rebecca Callahan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV risk and preventive interventions in transgender women sex workers

(2015) Tonia Poteat et al.   LANCET

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

(2015) Jeanne M. Marrazzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial

(2015) Madeline B Deutsch et al.   Lancet HIV

Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception

(2014) Pamela M. Murnane et al.   AIDS

Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception

(2014) Renee Heffron et al.   AIDS

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

(2014) Deborah Donnell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Treating a Transgender Patient: Overview of the Guidelines

(2014) Cory Wilczynski et al.   POSTGRADUATE MEDICINE

The Development of Sex Reassignment Surgery in Thailand: A Social Perspective

(2014) Prayuth Chokrungvaranont et al.   TheScientificWorldJOURNAL

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy

(2014) Olubanke Davies et al.   Journal of the International AIDS Society

Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)

(2013) Louis J Gooren et al.   ASIAN JOURNAL OF ANDROLOGY

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

(2013) Kachit Choopanya et al.   LANCET

Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand

(2013) Daniel Yang et al.   PLoS One

HIV surveillance and prevention in transgender women

(2012) Frits van Griensven et al.   LANCET INFECTIOUS DISEASES

Worldwide burden of HIV in transgender women: a systematic review and meta-analysis

(2012) Stefan D Baral et al.   LANCET INFECTIOUS DISEASES

Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

(2012) Michael C. Thigpen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of Effect of Tenofovir Disoproxil Fumarate on Pharmacokinetics of Hormonal Contraceptives

(2009) Brian P Kearney et al.   PHARMACOTHERAPY